Glenmark Pharmaceuticals Market Cap

Glenmark Pharmaceuticals has a market cap or net worth of 571.8 billion as of December 31, 2025. Its market cap has increased by 33.47% in one year.

Market Cap

571.80B

Enterprise Value

557.13B

Revenue

159.97B

Ranking

n/a

PE Ratio

56.62

Stock Price

2,035.90

Market Cap Chart

Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 571.80B, an increase of 49,651.47%. That is a compound annual growth rate of 28.73%.

Market Cap History

Date	Market Cap	% Change
Jan 1, 2026	571.80B	-0.44%
Dec 31, 2025	574.34B	26.49%
Dec 31, 2024	454.07B	88.44%
Dec 29, 2023	240.96B	101.33%
Dec 30, 2022	119.68B	-19.75%
Dec 31, 2021	149.14B	7.10%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Reliance Industries	20.84T
HDFC Bank	15.24T
Bharti Airtel	12.62T
Tata Consultancy Services	11.75T
ICICI Bank	9.60T
State Bank of India	8.99T
Infosys	6.56T
Bajaj Finance	6.14T

Market Cap Rankings